Amedisys (AMED) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Operating expenses: 347.24M
Today's EPS Names:
CCEL, MHGU, PLG, More
Financial Fact:
Operating expenses: 347.24M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q3 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $300.3 million versus the consensus estimate of $299.26 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- Mach Natural Resources (MNR) PT Lowered to $20 at Stephens
- Freedom Holding raises $300M in share offering at $126.35 per share
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
